 | • レポートコード：QYR9ST05289 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、院内感染治療薬の世界市場について調査・分析し、院内感染治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗菌薬、抗ウイルス薬、抗真菌薬）、用途別（院内感染肺炎、手術部位感染症、尿路感染症、胃腸障害、血流感染症、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の院内感染治療薬市場動向 ・主要企業別マーケットシェア ・院内感染治療薬の種類別市場規模2014-2019 （抗菌薬、抗ウイルス薬、抗真菌薬） ・院内感染治療薬の用途別市場規模2014-2019 （院内感染肺炎、手術部位感染症、尿路感染症、胃腸障害、血流感染症、その他） ・院内感染治療薬の北米市場：主要企業・種類別/用途別市場規模 ・院内感染治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・院内感染治療薬の中国市場：主要企業・種類別/用途別市場規模 ・院内感染治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・院内感染治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・院内感染治療薬のインド市場：主要企業・種類別/用途別市場規模 ・院内感染治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bayer、Johnson & Johnson Services、Actavis、Sanofi、Bristol Myers Squibb Company、AstraZeneca、Pfizer、Merck、GlaxoSmithkline、Cubist Pharmaceuticals） ・院内感染治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infections.The hospital infection therapeutics market is increasing at a significant rate, due to high susceptibility of neonatal population in healthcare setting and high occurrence of numerous hospital infections. Increasing incidences of hospital infections, high number of pipeline drug molecules for specific treatment of healthcare associated infections and high unaddressed needs in most of the countries are some of the factors providing ample opportunities for the hospital infection therapeutics market to grow in the coming years.
North America led the demand for hospital infection therapeutics market in 2017. The high prevalence of nosocomial infections has been identified as the key factor that has been driving the demand for infection therapeutics in North America and is projected to continue to do so throughout the forecast period. Although North America will remain the leading regional market for hospital infection therapeutics, it is Asia Pacific, which will present the most promising growth opportunities to this market in the near future.
In 2018, the global Hospital Infection Therapeutics market size was 2700 million US$ and it is expected to reach 3840 million US$ by the end of 2025, with a CAGR of 4.5% during 2019-2025.
This report focuses on the global Hospital Infection Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hospital Infection Therapeutics development in United States, Europe and China.
The key players covered in this study
Bayer
Johnson & Johnson Services
Actavis
Sanofi
Bristol Myers Squibb Company
AstraZeneca
Pfizer
Merck
GlaxoSmithkline
Cubist Pharmaceuticals
Market segment by Type, the product can be split into
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Market segment by Application, split into
Hospital Acquired Pneumonia
Surgical Site Infections
Urinary Tract Infection
Gastrointestinal Disorders
Bloodstream Infections
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hospital Infection Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Hospital Infection Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hospital Infection Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hospital Infection Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Antibacterial Drugs
1.4.3 Antiviral Drugs
1.4.4 Antifungal Drugs
1.5 Market by Application
1.5.1 Global Hospital Infection Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital Acquired Pneumonia
1.5.3 Surgical Site Infections
1.5.4 Urinary Tract Infection
1.5.5 Gastrointestinal Disorders
1.5.6 Bloodstream Infections
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hospital Infection Therapeutics Market Size
2.2 Hospital Infection Therapeutics Growth Trends by Regions
2.2.1 Hospital Infection Therapeutics Market Size by Regions (2014-2025)
2.2.2 Hospital Infection Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hospital Infection Therapeutics Market Size by Manufacturers
3.1.1 Global Hospital Infection Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Hospital Infection Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hospital Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Hospital Infection Therapeutics Key Players Head office and Area Served
3.3 Key Players Hospital Infection Therapeutics Product/Solution/Service
3.4 Date of Enter into Hospital Infection Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hospital Infection Therapeutics Market Size by Type (2014-2019)
4.2 Global Hospital Infection Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Hospital Infection Therapeutics Market Size (2014-2019)
5.2 Hospital Infection Therapeutics Key Players in United States
5.3 United States Hospital Infection Therapeutics Market Size by Type
5.4 United States Hospital Infection Therapeutics Market Size by Application
6 Europe
6.1 Europe Hospital Infection Therapeutics Market Size (2014-2019)
6.2 Hospital Infection Therapeutics Key Players in Europe
6.3 Europe Hospital Infection Therapeutics Market Size by Type
6.4 Europe Hospital Infection Therapeutics Market Size by Application
7 China
7.1 China Hospital Infection Therapeutics Market Size (2014-2019)
7.2 Hospital Infection Therapeutics Key Players in China
7.3 China Hospital Infection Therapeutics Market Size by Type
7.4 China Hospital Infection Therapeutics Market Size by Application
8 Japan
8.1 Japan Hospital Infection Therapeutics Market Size (2014-2019)
8.2 Hospital Infection Therapeutics Key Players in Japan
8.3 Japan Hospital Infection Therapeutics Market Size by Type
8.4 Japan Hospital Infection Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hospital Infection Therapeutics Market Size (2014-2019)
9.2 Hospital Infection Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Hospital Infection Therapeutics Market Size by Type
9.4 Southeast Asia Hospital Infection Therapeutics Market Size by Application
10 India
10.1 India Hospital Infection Therapeutics Market Size (2014-2019)
10.2 Hospital Infection Therapeutics Key Players in India
10.3 India Hospital Infection Therapeutics Market Size by Type
10.4 India Hospital Infection Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Hospital Infection Therapeutics Market Size (2014-2019)
11.2 Hospital Infection Therapeutics Key Players in Central & South America
11.3 Central & South America Hospital Infection Therapeutics Market Size by Type
11.4 Central & South America Hospital Infection Therapeutics Market Size by Application
12 International Players Profiles
12.1 Bayer
12.1.1 Bayer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hospital Infection Therapeutics Introduction
12.1.4 Bayer Revenue in Hospital Infection Therapeutics Business (2014-2019)
12.1.5 Bayer Recent Development
12.2 Johnson & Johnson Services
12.2.1 Johnson & Johnson Services Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hospital Infection Therapeutics Introduction
12.2.4 Johnson & Johnson Services Revenue in Hospital Infection Therapeutics Business (2014-2019)
12.2.5 Johnson & Johnson Services Recent Development
12.3 Actavis
12.3.1 Actavis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hospital Infection Therapeutics Introduction
12.3.4 Actavis Revenue in Hospital Infection Therapeutics Business (2014-2019)
12.3.5 Actavis Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hospital Infection Therapeutics Introduction
12.4.4 Sanofi Revenue in Hospital Infection Therapeutics Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Bristol Myers Squibb Company
12.5.1 Bristol Myers Squibb Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hospital Infection Therapeutics Introduction
12.5.4 Bristol Myers Squibb Company Revenue in Hospital Infection Therapeutics Business (2014-2019)
12.5.5 Bristol Myers Squibb Company Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hospital Infection Therapeutics Introduction
12.6.4 AstraZeneca Revenue in Hospital Infection Therapeutics Business (2014-2019)
12.6.5 AstraZeneca Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hospital Infection Therapeutics Introduction
12.7.4 Pfizer Revenue in Hospital Infection Therapeutics Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 Merck
12.8.1 Merck Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hospital Infection Therapeutics Introduction
12.8.4 Merck Revenue in Hospital Infection Therapeutics Business (2014-2019)
12.8.5 Merck Recent Development
12.9 GlaxoSmithkline
12.9.1 GlaxoSmithkline Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hospital Infection Therapeutics Introduction
12.9.4 GlaxoSmithkline Revenue in Hospital Infection Therapeutics Business (2014-2019)
12.9.5 GlaxoSmithkline Recent Development
12.10 Cubist Pharmaceuticals
12.10.1 Cubist Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Hospital Infection Therapeutics Introduction
12.10.4 Cubist Pharmaceuticals Revenue in Hospital Infection Therapeutics Business (2014-2019)
12.10.5 Cubist Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Hospital Infection Therapeutics Key Market Segments
Table Key Players Hospital Infection Therapeutics Covered
Table Global Hospital Infection Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hospital Infection Therapeutics Market Size Market Share by Type 2014-2025
Figure Antibacterial Drugs Figures
Table Key Players of Antibacterial Drugs
Figure Antiviral Drugs Figures
Table Key Players of Antiviral Drugs
Figure Antifungal Drugs Figures
Table Key Players of Antifungal Drugs
Table Global Hospital Infection Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Acquired Pneumonia Case Studies
Figure Surgical Site Infections Case Studies
Figure Urinary Tract Infection Case Studies
Figure Gastrointestinal Disorders Case Studies
Figure Bloodstream Infections Case Studies
Figure Others Case Studies
Figure Hospital Infection Therapeutics Report Years Considered
Table Global Hospital Infection Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Hospital Infection Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hospital Infection Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Hospital Infection Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Hospital Infection Therapeutics Market Share by Regions 2014-2019
Figure Global Hospital Infection Therapeutics Market Share by Regions 2014-2019
Figure Global Hospital Infection Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Hospital Infection Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hospital Infection Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Hospital Infection Therapeutics Market Share by Manufacturers in 2018
Table Global Hospital Infection Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hospital Infection Therapeutics Product/Solution/Service
Table Date of Enter into Hospital Infection Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hospital Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Hospital Infection Therapeutics Market Size Share by Type (2014-2019)
Figure Global Hospital Infection Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Hospital Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Hospital Infection Therapeutics Market Size Share by Application (2014-2019)
Figure Global Hospital Infection Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Hospital Infection Therapeutics Revenue Market Share by Application in 2018
Figure United States Hospital Infection Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Hospital Infection Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Hospital Infection Therapeutics Market Share (2018-2019)
Table United States Hospital Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Hospital Infection Therapeutics Market Share by Type (2014-2019)
Table United States Hospital Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Hospital Infection Therapeutics Market Share by Application (2014-2019)
Figure Europe Hospital Infection Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Hospital Infection Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Hospital Infection Therapeutics Market Share (2018-2019)
Table Europe Hospital Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Hospital Infection Therapeutics Market Share by Type (2014-2019)
Table Europe Hospital Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Hospital Infection Therapeutics Market Share by Application (2014-2019)
Figure China Hospital Infection Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Hospital Infection Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Hospital Infection Therapeutics Market Share (2018-2019)
Table China Hospital Infection Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Hospital Infection Therapeutics Market Share by Type (2014-2019)
Table China Hospital Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Hospital Infection Therapeutics Market Share by Application (2014-2019)
Figure Japan Hospital Infection Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Hospital Infection Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Hospital Infection Therapeutics Market Share (2018-2019)
Table Japan Hospital Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Hospital Infection Therapeutics Market Share by Type (2014-2019)
Table Japan Hospital Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Hospital Infection Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Hospital Infection Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hospital Infection Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hospital Infection Therapeutics Market Share (2018-2019)
Table Southeast Asia Hospital Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hospital Infection Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Hospital Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hospital Infection Therapeutics Market Share by Application (2014-2019)
Figure India Hospital Infection Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Hospital Infection Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Hospital Infection Therapeutics Market Share (2018-2019)
Table India Hospital Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Hospital Infection Therapeutics Market Share by Type (2014-2019)
Table India Hospital Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Hospital Infection Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Hospital Infection Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hospital Infection Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hospital Infection Therapeutics Market Share (2018-2019)
Table Central & South America Hospital Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hospital Infection Therapeutics Market Share by Type (2014-2019)
Table Central & South America Hospital Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hospital Infection Therapeutics Market Share by Application (2014-2019)
Table Bayer Company Details
Table Bayer Revenue in Hospital Infection Therapeutics Business (2014-2019) (Million US$)
Figure Bayer Revenue Growth Rate in Hospital Infection Therapeutics Business (2014-2019)
Table Bayer Recent Development
Table Johnson & Johnson Services Company Details
Table Johnson & Johnson Services Revenue in Hospital Infection Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Services Revenue Growth Rate in Hospital Infection Therapeutics Business (2014-2019)
Table Johnson & Johnson Services Recent Development
Table Actavis Company Details
Table Actavis Revenue in Hospital Infection Therapeutics Business (2014-2019)(Million US$)
Figure Actavis Revenue Growth Rate in Hospital Infection Therapeutics Business (2014-2019)
Table Actavis Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Hospital Infection Therapeutics Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Hospital Infection Therapeutics Business (2014-2019)
Table Sanofi Recent Development
Table Bristol Myers Squibb Company Company Details
Table Bristol Myers Squibb Company Revenue in Hospital Infection Therapeutics Business (2014-2019)(Million US$)
Figure Bristol Myers Squibb Company Revenue Growth Rate in Hospital Infection Therapeutics Business (2014-2019)
Table Bristol Myers Squibb Company Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Hospital Infection Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Hospital Infection Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Hospital Infection Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Hospital Infection Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Merck Company Details
Table Merck Revenue in Hospital Infection Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Hospital Infection Therapeutics Business (2014-2019)
Table Merck Recent Development
Table GlaxoSmithkline Company Details
Table GlaxoSmithkline Revenue in Hospital Infection Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithkline Revenue Growth Rate in Hospital Infection Therapeutics Business (2014-2019)
Table GlaxoSmithkline Recent Development
Table Cubist Pharmaceuticals Company Details
Table Cubist Pharmaceuticals Revenue in Hospital Infection Therapeutics Business (2014-2019)(Million US$)
Figure Cubist Pharmaceuticals Revenue Growth Rate in Hospital Infection Therapeutics Business (2014-2019)
Table Cubist Pharmaceuticals Recent Development
Table Global Hospital Infection Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Hospital Infection Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Hospital Infection Therapeutics Market Size Share by Regions in 2025
Figure United States Hospital Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hospital Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Hospital Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hospital Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hospital Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Hospital Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hospital Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Hospital Infection Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Hospital Infection Therapeutics Market Size by Product (2019-2025)
Figure Global Hospital Infection Therapeutics Market Size by Product in 2025
Table Global Hospital Infection Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Hospital Infection Therapeutics Market Size by Application (2019-2025)
Figure Global Hospital Infection Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
院内感染治療薬の世界市場：市場規模・現状・予測 Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infec…- 院内感染制御の世界市場：市場規模・現状・予測 A hospital-acquired infection (HAI), also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility.The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infection…
- 院内感染治療の世界市場：市場規模・現状・予測 Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. In 2018, the global Hospital Acquired Infection Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2…
- 院内尿路感染症の世界市場：インサイト・予測 Hospital acquired urinary tract infections are caused by patients urethral catheters or invasive manipulation in the urogenital tract, which allows microbes to enter into the bladder and encourages proliferation by providing a sustainable environment.They are accountable for over 50% of infections. …
- 尿路感染症治療の世界市場：市場規模・現状・予測 Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland.This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasing…